everyledgerAn index of 679,731 U.S. nonprofits · computed from public IRS filings · current through 2024

The Mark Foundation For Cancer Research Us Ltd

New York, NY / EIN 36-4825921 / Form 990 / latest filing 2023
Operating record · U.S. dollars
Fiscal yearRevenueExpensesNetReserve mo.Staff %
2015000
2016500,000290,901209,0998.60%
201710,550,1355,432,8885,117,24711.814%
201840,519,11838,540,0211,979,0973.14%
201980,534,92447,346,92933,187,99511.04%
202040,176,29921,645,74718,530,55236.312%
202137,486,88335,686,7091,800,17423.46%
202255,345,49438,014,60617,330,88826.17%
202340,937,63235,209,4975,728,13528.88%

In its most recent public year (2023), this organization brought in $5,728,135 more than it spent. Its reserves stood at about 28.8 months of spending. Staff pay was 8% of spending. $3,623,066 of its net assets are donor-restricted.

Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings

Get this record as a feed

The Mark Foundation For Cancer Research Us Ltd's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works